YOU ARE HERE: LAT HomeCollections

Solving Medical Mysteries

May 12, 1990|EVE BELSON | Eve Belson is a regular contributor to Orange County Life

People had been watching apples fall out of trees long before Sir Isaac Newton ever contemplated the notion of gravity. What led to his portentous theories about bodies in motion was his freshness of vision while sitting under the apple tree.

That ability to look at a phenomenon from an unorthodox angle or to recognize its potential is still the hallmark of scientific breakthrough.

Researchers at UC Irvine are currently working on a crop of inspired projects that may not only solve a number of medical conundrums but also change the way we view health and fitness over the next decade.

Until recently, back injuries were routinely treated with lots of rest, massage, hot packs and ultrasound. But Dr. Vert Mooney, chair of orthopedic surgery at UCI, is prescribing exercise--lots of it.

"The project is to treat soft-tissue injuries, which is what a back injury basically is, in a sports medicine attitude," he says. That means gradually progressive exercises, the kind that get top athletes back in action in days instead of the weeks and even months it normally takes using traditional methods.

Scientific studies indicate that only exercise can "tell" soft tissues to repair themselves. The absence of physical mechanical stress is essentially destructive, according to Mooney.

"This treatment is more rational if you start measuring what an individual can do rather than what they say they feel," he says.

In other words, how much the treatment bothers the patient is not nearly as important as measuring the increasing strength of the back tissues.

To document patient recovery, Mooney has been using computerized equipment to evaluate muscle function and back strength in back injury patients. Because 40% of all workers' compensation cases involve back injuries, the long-term implications for insurance companies could be enormous if treatment time for such injuries could be reduced from months to weeks, or even days.

Our notions of environmental safety may be shaken up by two other studies at UCI.

The recent uproar over the spraying of malathion has prompted Elaine Vaughn, assistant professor of social ecology, to look into the psychology of risk perception.

In a study that will begin in late spring, Vaughn will test her hypothesis that factors other than pure scientific estimates cause people to perceive risks differently. To determine which factors most influence our risk perceptions, she will ask subjects to evaluate the severity of a fictitious pesticide risk based on simulated news broadcasts.

The disparities that have been documented between experts and non-experts in their judgment of environmental hazards may be attributed to prior beliefs which they bring to the evaluation process, according to Vaughn. She hopes the study will help pinpoint whether the credibility of the source or the proximity of the risk can overcome previous bias.

Meanwhile, Dr. Robert Phalen, professor of community and environmental medicine, has shown that rats intermittently exposed to polluted air exhibited greater lung damage than rats constantly exposed to the same pollutants. These surprising results may indicate that lung tissues adjust and adapt under continuous exposure, while intermittent exposure does not allow that protection to develop.

Phalen is now seeking funding for a six-month study designed to verify his findings, which may eventually lead to a rethinking of air pollution control strategies. "The general concern that is emerging in the scientific community is that in the past we might have been focusing a little too much on the acute effects of air pollutants and not enough on longer term effects," he says.

Pfizer Inc., the Connecticut-based pharmaceutical giant, recently awarded a two-year grant of $1.5 million to a UCI research project that has discovered the first molecular marker linking such autoimmune diseases as diabetes, multiple sclerosis, lupus and rheumatoid arthritis, which together affect between 150 million and 200 million people worldwide.

"The discovery was pure chance," says Dr. George Chandy, assistant professor of physiology and medicine, who heads the project along with Dr. Stephen Grissmer, a postdoctoral researcher, and Dr. Michael Cahalan, professor of physiology and biophysics.

As Chandy explains it, the researchers "were playing around" one Saturday night back in 1986 with a class of immune cells, called double negative T-cells, in mice infected with lupus.

They noticed that the cells exhibited abnormally high numbers of specific types of potassium channels, the protein on the cells' surfaces which regulate the activity of the nervous system and the heart. It is these abnormal immune cells which appear to trigger other immune cells to destroy tissues in the body, a hallmark of autoimmune diseases.

The scientists believe that this channel abnormality might serve as a "diagnostic marker" for drugs designed to block the potassium channels and intervene in the development and progression of these diseases.

Los Angeles Times Articles